Literature DB >> 29439605

Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury.

Stephanie W Lee1, Shyam Gajavelli1, Markus S Spurlock1, Cody Andreoni1, Juan Pablo de Rivero Vaccari1, M Ross Bullock1, Robert W Keane1,2, W Dalton Dietrich1.   

Abstract

Penetrating traumatic brain injury (PTBI) is a significant cause of death and disability in the United States. Inflammasomes are one of the key regulators of the interleukin (IL)-1β mediated inflammatory responses after traumatic brain injury. However, the contribution of inflammasome signaling after PTBI has not been determined. In this study, adult male Sprague-Dawley rats were subjected to sham procedures or penetrating ballistic-like brain injury (PBBI) and sacrificed at various time-points. Tissues were assessed by immunoblot analysis for expression of IL-1β, IL-18, and components of the inflammasome: apoptosis-associated speck-like protein containing a caspase-activation and recruitment domain (ASC), caspase-1, X-linked inhibitor of apoptosis protein (XIAP), nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3), and gasdermin-D (GSDMD). Specific cell types expressing inflammasome proteins also were evaluated immunohistochemically and assessed quantitatively. After PBBI, expression of IL-1β, IL-18, caspase-1, ASC, XIAP, and NLRP3 peaked around 48 h. Brain protein lysates from PTBI animals showed pyroptosome formation evidenced by ASC laddering, and also contained increased expression of GSDMD at 48 h after injury. ASC-positive immunoreactive neurons within the perilesional cortex were observed at 24 h. At 48 h, ASC expression was concentrated in morphologically activated cortical microglia. This expression of ASC in activated microglia persisted until 12 weeks following PBBI. This is the first report of inflammasome activation after PBBI. Our results demonstrate cell-specific patterns of inflammasome activation and pyroptosis predominantly in microglia, suggesting a sustained pro-inflammatory state following PBBI, thus offering a therapeutic target for this type of brain injury.

Entities:  

Keywords:  inflammasome; microglia; penetrating ballistic-like brain injury; penetrating traumatic brain injury

Mesh:

Substances:

Year:  2018        PMID: 29439605      PMCID: PMC6016174          DOI: 10.1089/neu.2017.5530

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  80 in total

1.  Characterization of a new rat model of penetrating ballistic brain injury.

Authors:  Anthony J Williams; Jed A Hartings; X-C May Lu; Michael L Rolli; Jitendra R Dave; Frank C Tortella
Journal:  J Neurotrauma       Date:  2005-02       Impact factor: 5.269

2.  Exosome-mediated inflammasome signaling after central nervous system injury.

Authors:  Juan Pablo de Rivero Vaccari; Frank Brand; Stephanie Adamczak; Stephanie W Lee; Jon Perez-Barcena; Michael Y Wang; M Ross Bullock; W Dalton Dietrich; Robert W Keane
Journal:  J Neurochem       Date:  2015-03-01       Impact factor: 5.372

3.  Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease.

Authors:  Carmen Venegas; Sathish Kumar; Bernardo S Franklin; Tobias Dierkes; Rebecca Brinkschulte; Dario Tejera; Ana Vieira-Saecker; Stephanie Schwartz; Francesco Santarelli; Markus P Kummer; Angelika Griep; Ellen Gelpi; Michael Beilharz; Dietmar Riedel; Douglas T Golenbock; Matthias Geyer; Jochen Walter; Eicke Latz; Michael T Heneka
Journal:  Nature       Date:  2017-12-20       Impact factor: 49.962

4.  Apoptotic and antiapoptotic mechanisms after traumatic brain injury.

Authors:  R W Keane; S Kraydieh; G Lotocki; O F Alonso; P Aldana; W D Dietrich
Journal:  J Cereb Blood Flow Metab       Date:  2001-10       Impact factor: 6.200

5.  Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events.

Authors:  R Bullock; A Zauner; J S Myseros; A Marmarou; J J Woodward; H F Young
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

6.  Mangiferin attenuates blast-induced traumatic brain injury via inhibiting NLRP3 inflammasome.

Authors:  Kaihua Fan; Jie Ma; Wenjing Xiao; Jingmin Chen; Juan Wu; Jiandong Ren; Jun Hou; Yonghe Hu; Jianwen Gu; Botao Yu
Journal:  Chem Biol Interact       Date:  2017-04-25       Impact factor: 5.192

Review 7.  Routine techniques in forensic neuropathology as demonstrated by gunshot injury to the head.

Authors:  Manfred Oehmichen; Christoph Meissner
Journal:  Leg Med (Tokyo)       Date:  2009-03-10       Impact factor: 1.376

8.  Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy.

Authors:  Stefano Signoretti; Anthony Marmarou; Gunes A Aygok; Panos P Fatouros; Gina Portella; Ross M Bullock
Journal:  J Neurosurg       Date:  2008-01       Impact factor: 5.115

Review 9.  Microglia in the TBI brain: The good, the bad, and the dysregulated.

Authors:  David J Loane; Alok Kumar
Journal:  Exp Neurol       Date:  2015-09-03       Impact factor: 5.330

10.  "Time is brain" the Gifford factor - or: Why do some civilian gunshot wounds to the head do unexpectedly well? A case series with outcomes analysis and a management guide.

Authors:  David J Lin; Fred C Lam; Jeffrey J Siracuse; Ajith Thomas; Ekkehard M Kasper
Journal:  Surg Neurol Int       Date:  2012-08-27
View more
  26 in total

1.  Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.

Authors:  Irving Parra; Isabel Martínez; Gabriel Ramírez-García; Yousef Tizabi; Liliana Mendieta
Journal:  Neurotox Res       Date:  2019-09-02       Impact factor: 3.911

2.  Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation.

Authors:  Changwen Zhang; Ayyiliath M Sajith; Xiaotian Xu; Jianxiong Jiang; J Phillip Bowen; Amol Kulkarni; Jiukuan Hao
Journal:  Bioorg Med Chem       Date:  2022-01-31       Impact factor: 3.641

3.  LncRNA Tug1 Contributes Post-stroke NLRP3 Inflammasome-Dependent Pyroptosis via miR-145a-5p/Tlr4 Axis.

Authors:  Meiling Yao; Ying Luo; Hongjie Li; Songjie Liao; Jian Yu
Journal:  Mol Neurobiol       Date:  2022-08-22       Impact factor: 5.682

Review 4.  Gasdermin Family: a Promising Therapeutic Target for Stroke.

Authors:  Sheng Chen; Shuhao Mei; Yujie Luo; Hemmings Wu; Jianmin Zhang; Junming Zhu
Journal:  Transl Stroke Res       Date:  2018-10-03       Impact factor: 6.829

5.  The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury.

Authors:  Andrea Crespo-Castrillo; Natalia Yanguas-Casás; Maria Angeles Arevalo; Iñigo Azcoitia; George E Barreto; Luis M Garcia-Segura
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

6.  Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice.

Authors:  Noelia Granado; Sara Ares-Santos; Yousef Tizabi; Rosario Moratalla
Journal:  Neurotox Res       Date:  2018-06-22       Impact factor: 3.911

7.  Acid sphingomyelinase deficiency protects mitochondria and improves function recovery after brain injury.

Authors:  Sergei A Novgorodov; Joshua R Voltin; Wenxue Wang; Stephen Tomlinson; Christopher L Riley; Tatyana I Gudz
Journal:  J Lipid Res       Date:  2019-01-20       Impact factor: 5.922

Review 8.  Neural-respiratory inflammasome axis in traumatic brain injury.

Authors:  Nadine Kerr; Juan Pablo de Rivero Vaccari; W Dalton Dietrich; Robert W Keane
Journal:  Exp Neurol       Date:  2019-10-15       Impact factor: 5.330

Review 9.  Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases.

Authors:  Bo-Zong Shao; Qi Cao; Chong Liu
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 5.639

Review 10.  Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation.

Authors:  Andrea Crespo-Castrillo; Maria-Angeles Arevalo
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.